FDA inspection
AbbVie Inc.: FDA inspection ending Jan 31, 2023
FDA inspection 1198013 · Voluntary Action Indicated (VAI) · North Chicago, IL
Key facts
| Inspection ID | 1198013 |
|---|---|
| Firm | AbbVie Inc. |
| FEI number | 3009751352 |
| Address | 1 N Waukegan Rd |
| City | North Chicago |
| State | IL |
| ZIP | 60064 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Jan 31, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data